Search results for "Heart failure"


 
Results 81 - 90 of about 462 for "Heart failure".
Sort by: Relevance | Newest | Oldest

Beta-blockers not associated with lower risk of death after acute MI in patients without heart failure, study finds

The insignificant effect of beta-blockers on survival was also apparent at one month and six months after discharge, as well as in separate analyses of patients with STEMI and NSTEMI.
https://immattersacp.org/weekly/archives/2017/06/06/5.htm
6 Jun 2017

A living guideline for depression treatment

ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023

Effects of heart failure therapies on quality of life compared

Sacubitril/valsartan may improve limitations in physical and social activities that are important to patients with heart failure, researchers noted.
https://immattersacp.org/weekly/archives/2018/04/10/1.htm
10 Apr 2018

Cardiac rehab uptake remains low, despite benefits

Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022

Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes

Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016

Sacubitril-valsartan appears cost-effective in certain heart failure patients

Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2022

A pre-flight check for patients

People with cardiopulmonary or hematologic disorders can be affected by the hypobaric environment aboard an aircraft, so they should undergo preflight evaluation before lift-off.
https://immattersacp.org/archives/2019/05/a-pre-flight-check-for-patients.htm
1 May 2019

Combat cardiac risks of cancer therapies

One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018

Treating skin ulcers in the office

In addition to five principles of wound care, an expert addresses pearls that can aid with all types of skin healing and antimicrobial efforts.
https://immattersacp.org/archives/2020/06/treating-skin-ulcers-in-the-office.htm
1 Jun 2020

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next